Siyaram Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Kolkata, West Bengal, India, established in 2010.
2010 Kolkata, West Bengal, India Struck Off
Last Updated:
About Siyaram Pharmaceuticals Private Limited

Siyaram Pharmaceuticals Private Limited, a struck off private limited company, was established on 22 December 2010 in Kolkata, West Bengal, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85195WB2010PTC156077. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Subir Ranjan Das (Director), Sudipa Roychowdhury (Director). Past directors included Krishnendu Ghosh, Jhilik Prasanna Bhattacharya, Pralay Kanta Bhattacharyya. It is based at 7, Panditiya Place, 2Nd Floor, Kolkata, West Bengal, 700029.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85195WB2010PTC156077

  • Registration Number

    156077

  • Incorporation Date

    22 December 2010

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 2 Months
Company report

Siyaram Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Siyaram Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Siyaram Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Subir Ranjan Das Director 22 Dec 2010 Current
Sudipa Roychowdhury Director 22 Dec 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Dec 2013 Past
Pramod Abcsdd Director 22 Nov 2013 Past
Pramod Abcsdd Director 17 Jun 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Siyaram Pharmaceuticals.

Enhance accessibility to Siyaram Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Siyaram Pharmaceuticals revenue growth over time
Siyaram Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Siyaram Pharmaceuticals?

Unlock access to Siyaram Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Siyaram Pharmaceuticals?

Unlock and access historical data on people associated with Siyaram Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Siyaram Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siyaram Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Siyaram Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Subir Ranjan Das was appointed as a Director was appointed as a Director on 22 Dec 2010 & has been associated with this company since 15 years 2 months . was completed.

  • Director Appointment

    Progress on Sudipa Roychowdhury was appointed as a Director was appointed as a Director on 22 Dec 2010 & has been associated with this company since 15 years 2 months . was documented.

  • Company Incorporation

    The activity Siyaram Pharmaceuticals Private Limited was registered on 22 Dec 2010 with Roc Kolkata & aged 15 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Siyaram Pharmaceuticals Private Limited?

The CIN of Siyaram Pharmaceuticals Private Limited is U85195WB2010PTC156077.

Where is Siyaram Pharmaceuticals Private Limited headquartered?

Siyaram Pharmaceuticals Private Limited is headquartered at 7, Panditiya Place, 2Nd Floor, Kolkata, West Bengal, 700029.

When was Siyaram Pharmaceuticals Private Limited incorporated?

Siyaram Pharmaceuticals Private Limited was incorporated on 22 December 2010.

Who are the current directors of Siyaram Pharmaceuticals Private Limited?

The current directors of Siyaram Pharmaceuticals Private Limited are

What is the primary industry of Siyaram Pharmaceuticals Private Limited?

The primary industry of Siyaram Pharmaceuticals Private Limited is Healthcare.

Is Siyaram Pharmaceuticals Private Limited a listed company?

Siyaram Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Siyaram Pharmaceuticals Private Limited?

The authorized capital of Siyaram Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available